Literature DB >> 25278557

RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Alana C Cecchi1, Dongchuan Guo1, Zhao Ren1, Kelly Flynn1, Regie Lyn P Santos-Cortez1, Suzanne M Leal1, Gao T Wang1, Ellen S Regalado1, Gary K Steinberg1, Jay Shendure1, Michael J Bamshad1, James C Grotta1, Deborah A Nickerson1, Hariyadarshi Pannu1, Dianna M Milewicz2.   

Abstract

BACKGROUND AND
PURPOSE: Moyamoya disease (MMD) is a rare, genetically heterogeneous cerebrovascular disease resulting from occlusion of the distal internal carotid arteries. A variant in the Ring Finger 213 gene (RNF213), altering arginine at position 4810 (p.R4810K), is associated with MMD in Asian populations. However, there are a lack of data on the role of RNF213 in patients with MMD of additional ethnicities and diasporic Asian populations. We investigate the contribution of RNF213 alterations to MMD in an ethnically diverse population based in the United States.
METHODS: We initially sequenced RNF213 exons 43, 44, and 45 (encoding the eponymous RING finger domain) and exon 60 (encoding p.R4810K) in 86 ethnically diverse patients with MMD. Comprehensive exome sequencing data from 24 additional patients with MMD was then analyzed to identify RNF213 variants globally. Segregation of variants with MMD and other vascular diseases was assessed in families.
RESULTS: RNF213 p.R4810K was identified in 56% (9/16) of patients with MMD of Asian descent and not in 94 patients of non-Asian descent. 3.6% (4/110) of patients had variants in the exons encoding the RING finger domain. Seven additional variants were identified in 29% (7/24) of patients with MMD who underwent exome sequencing. Segregation analysis supported an association with MMD for 2 variants and a lack of association with disease for 1 variant.
CONCLUSIONS: These results confirm that alterations in RNF213 predispose patients of diverse ethnicities to MMD, and that the p.R4810K variant predisposes individuals of Asian descent in the United States to MMD.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  RNF213 protein, human; moyamoya disease; stroke

Mesh:

Substances:

Year:  2014        PMID: 25278557      PMCID: PMC4420622          DOI: 10.1161/STROKEAHA.114.006244

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  Predicting deleterious amino acid substitutions.

Authors:  P C Ng; S Henikoff
Journal:  Genome Res       Date:  2001-05       Impact factor: 9.043

2.  Exact genetic linkage computations for general pedigrees.

Authors:  M Fishelson; D Geiger
Journal:  Bioinformatics       Date:  2002       Impact factor: 6.937

3.  Rapid progression of unilateral moyamoya disease in a patient with a family history and an RNF213 risk variant.

Authors:  Yohei Mineharu; Yasushi Takagi; Jun C Takahashi; Hirokuni Hashikata; Wanyang Liu; Toshiaki Hitomi; Hatasu Kobayashi; Akio Koizumi; Susumu Miyamoto
Journal:  Cerebrovasc Dis       Date:  2013-09-11       Impact factor: 2.762

4.  Variant association tools for quality control and analysis of large-scale sequence and genotyping array data.

Authors:  Gao T Wang; Bo Peng; Suzanne M Leal
Journal:  Am J Hum Genet       Date:  2014-05-01       Impact factor: 11.025

Review 5.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

6.  Smooth muscle hyperplasia due to loss of smooth muscle α-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-β.

Authors:  Christina L Papke; Jiumei Cao; Callie S Kwartler; Carlos Villamizar; Katerina L Byanova; Soon-Mi Lim; Harini Sreenivasappa; Grant Fischer; John Pham; Meredith Rees; Miranda Wang; Christine Chaponnier; Giulio Gabbiani; Aarif Y Khakoo; Joya Chandra; Andreea Trache; Warren Zimmer; Dianna M Milewicz
Journal:  Hum Mol Genet       Date:  2013-04-15       Impact factor: 6.150

Review 7.  Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality.

Authors:  Binita M Kamath; Nancy B Spinner; Karan M Emerick; Albert E Chudley; Carol Booth; David A Piccoli; Ian D Krantz
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

8.  Moyamoya disease associated with asymptomatic mosaic Turner syndrome: a rare cause of hemorrhagic stroke.

Authors:  Sunil Manjila; Benjamin R Miller; Anitha Rao-Frisch; Balint Otvos; Anna Mitchell; Nicholas C Bambakidis; Michael A De Georgia
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-10-06       Impact factor: 2.136

9.  Ensembl 2014.

Authors:  Paul Flicek; M Ridwan Amode; Daniel Barrell; Kathryn Beal; Konstantinos Billis; Simon Brent; Denise Carvalho-Silva; Peter Clapham; Guy Coates; Stephen Fitzgerald; Laurent Gil; Carlos García Girón; Leo Gordon; Thibaut Hourlier; Sarah Hunt; Nathan Johnson; Thomas Juettemann; Andreas K Kähäri; Stephen Keenan; Eugene Kulesha; Fergal J Martin; Thomas Maurel; William M McLaren; Daniel N Murphy; Rishi Nag; Bert Overduin; Miguel Pignatelli; Bethan Pritchard; Emily Pritchard; Harpreet S Riat; Magali Ruffier; Daniel Sheppard; Kieron Taylor; Anja Thormann; Stephen J Trevanion; Alessandro Vullo; Steven P Wilder; Mark Wilson; Amonida Zadissa; Bronwen L Aken; Ewan Birney; Fiona Cunningham; Jennifer Harrow; Javier Herrero; Tim J P Hubbard; Rhoda Kinsella; Matthieu Muffato; Anne Parker; Giulietta Spudich; Andy Yates; Daniel R Zerbino; Stephen M J Searle
Journal:  Nucleic Acids Res       Date:  2013-12-06       Impact factor: 16.971

10.  A general framework for estimating the relative pathogenicity of human genetic variants.

Authors:  Martin Kircher; Daniela M Witten; Preti Jain; Brian J O'Roak; Gregory M Cooper; Jay Shendure
Journal:  Nat Genet       Date:  2014-02-02       Impact factor: 38.330

View more
  47 in total

1.  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.

Authors:  Stéphanie Guey; Markus Kraemer; Dominique Hervé; Thomas Ludwig; Manoëlle Kossorotoff; Françoise Bergametti; Jan Claudius Schwitalla; Simone Choi; Lucile Broseus; Isabelle Callebaut; Emmanuelle Genin; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

2.  Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant.

Authors:  Tamar Harel; Jennifer E Posey; Brett H Graham; Magdalena Walkiewicz; Yaping Yang; Seema R Lalani; John W Belmont
Journal:  Am J Med Genet A       Date:  2015-07-21       Impact factor: 2.802

3.  Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.

Authors:  Jeffrie Hadisurya; Stephanie Guey; Lou Grangeon; Dagmar Wieczorek; Michaelle Corpechot; Jan Claudius Schwitalla; Markus Kraemer
Journal:  Childs Nerv Syst       Date:  2019-04-29       Impact factor: 1.475

4.  RNF213 Is Associated with Intracranial Aneurysms in the French-Canadian Population.

Authors:  Sirui Zhou; Amirthagowri Ambalavanan; Daniel Rochefort; Pingxing Xie; Cynthia V Bourassa; Pascale Hince; Alexandre Dionne-Laporte; Dan Spiegelman; Ziv Gan-Or; Cathy Mirarchi; Vessela Zaharieva; Nicolas Dupré; Hatasu Kobayashi; Toshiaki Hitomi; Kouji Harada; Akio Koizumi; Lan Xiong; Patrick A Dion; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2016-10-13       Impact factor: 11.025

5.  RNF213 variants in a child with PHACE syndrome and moyamoya vasculopathy.

Authors:  Kala F Schilter; Jack E Steiner; Wendy Demos; Mohit Maheshwari; Jeremy W Prokop; Elizabeth Worthey; Beth A Drolet; Dawn H Siegel
Journal:  Am J Med Genet A       Date:  2017-07-07       Impact factor: 2.802

Review 6.  Childhood stroke.

Authors:  Peter B Sporns; Heather J Fullerton; Sarah Lee; Helen Kim; Warren D Lo; Mark T Mackay; Moritz Wildgruber
Journal:  Nat Rev Dis Primers       Date:  2022-02-24       Impact factor: 52.329

7.  Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.

Authors:  S Wallace; D-C Guo; E Regalado; L Mellor-Crummey; M Bamshad; D A Nickerson; R Dauser; N Hanchard; R Marom; E Martin; V Berka; I Sharina; V Ganesan; D Saunders; S A Morris; D M Milewicz
Journal:  Clin Genet       Date:  2016-02-18       Impact factor: 4.438

8.  The association between the ring finger protein 213 (RNF213) polymorphisms and moyamoya disease susceptibility: a meta-analysis based on case-control studies.

Authors:  Xun-Sha Sun; Jun Wen; Jiao-Xing Li; Rong Lai; Yu-Fang Wang; Hui-Jiao Liu; Wen-Li Sheng
Journal:  Mol Genet Genomics       Date:  2016-02-05       Impact factor: 3.291

Review 9.  Moyamoya Disease and Spectrums of RNF213 Vasculopathy.

Authors:  Oh Young Bang; Jong-Won Chung; Dong Hee Kim; Hong-Hee Won; Je Young Yeon; Chang-Seok Ki; Hyung Jin Shin; Jong-Soo Kim; Seung Chyul Hong; Duk-Kyung Kim; Akio Koizumi
Journal:  Transl Stroke Res       Date:  2019-10-24       Impact factor: 6.829

10.  Association of De Novo RNF213 Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.

Authors:  Amélie Pinard; Maximillian D J Fiander; Alana C Cecchi; Andrea L Rideout; Mohamed Azouz; Stuart M Fraser; P Daniel McNeely; Simon Walling; Sarah C Novara; Anna C E Hurst; Dongchuan Guo; Sandhya Parkash; Michael J Bamshad; Deborah A Nickerson; Anthony M Vandersteen; Dianna M Milewicz
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.